Chronic Stenotrophomonas maltophilia infection in cystic fibrosis (CF) patients has recently been shown to be an independent risk factor for pulmonary exacerbation [ 1 x [1] Waters, V., Yau, Y., Prasad, S., Lu, A., Atenafu, E., Crandall, I. et al. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. Am J Respir Crit Care Med. 2011; 183: 635–640 Crossref | PubMed | Scopus (88) | Google Scholar See all References ] [1] . Antibiotic use, however, is a known risk factor for the isolation of S. maltophilia in the respiratory tract of CF patients and increased treatment of pulmonary exacerbations may simply be selecting out S. maltophilia in the airways of sicker CF patients [ 2 x [2] Marchac, V., Equi, A., Le Bihan-Benjamin, C., Hodson, M., and Bush, A. Case–control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients. Eur Respir J. 2004; 23: 98–102 Crossref | PubMed | Scopus (43) | Google Scholar See all References , 3 x [3] Talmaciu, I., Varlotta, L., Mortensen, J., and Schidlow, D.V. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis. Pediatr Pulmonol. 2000; 30: 10–15 Crossref | PubMed | Scopus (66) | Google Scholar See all References , 4 x [4] Graff, G.R. and Burns, J.L. Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis. Chest. 2002; 121: 1754–1760 Crossref | PubMed | Scopus (58) | Google Scholar See all References , 5 x [5] Denton, M., Todd, N.J., Kerr, K.G., Hawkey, P.M., and Littlewood, J.M. Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples. J Clin Microbiol. 1998; 36: 1953–1958 PubMed | Google Scholar See all References ]. The consequences of the increased number of pulmonary exacerbations in CF patients with chronic S. maltophilia infection are unknown.